Torrent Pharma Completes JB Chemicals Acquisition, Becomes Promoter with 46.39% Stake
New Delhi: Torrent Pharmaceuticals Limited has completed the acquisition of a controlling stake in J.B. Chemicals & Pharmaceuticals Limited, officially becoming its promoter with effect from January 21, 2026. The acquisition involves 7,44,81,519 equity shares, representing 46.39%% of the equity share capital of JB Chemicals on a fully diluted basis.
The transaction was carried out under a share purchase agreement dated June 29, 2025, executed between Torrent Pharmaceuticals, Tau Investment Holdings Pte. Ltd. - the promoter seller - and J.B. Chemicals & Pharmaceuticals Limited, along with an addendum dated July 3, 2025. The acquisition follows a series of prior disclosures made by Torrent Pharmaceuticals to the stock exchanges between June and December 2025 regarding the proposed transaction.
With the completion of this acquisition, Torrent Pharmaceuticals has gained control over JB Chemicals and has been classified as a ‘promoter’ of the company with effect from January 21, 2026, in accordance with applicable regulatory norms.
In addition to the shares acquired from the promoter seller, Torrent Pharmaceuticals also purchased 1,317 equity shares of JB Chemicals through an open offer. As a result, the company now holds an aggregate of 7,44,82,836 equity shares, accounting for 46.39% of JB Chemicals’ equity share capital on a fully diluted basis.
The company has informed both the Bombay Stock Exchange and the National Stock Exchange of India about the completion of the acquisition under Regulation 30 and Regulation 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Torrent Pharmaceuticals is listed on the BSE under scrip code 500420 and on the NSE under the symbol TORNTPHARM.
Torrent Pharmaceuticals stated that the acquisition aligns with its long-term strategic objectives and strengthens its presence across key therapeutic segments. The company has requested the stock exchanges to take the disclosure on record.
Torrent Pharmaceuticals Limited is headquartered in Ahmedabad, Gujarat, and the disclosure was signed by Chintan M. Trivedi, Company Secretary of the company.
